Italian Oncology at the Crossroads: Between Hospital Bed Cuts and the Need for a Transition to Integrated Community-Based Simultaneous Care [0.03%]
意大利肿瘤学面临抉择：在减少住院床位和转型为综合社区基护理之间徘徊
Lavinia Gentile,Stefania Moramarco,Edoardo Carnevale et al.
Lavinia Gentile et al.
Background: In Italy, public health investments have not kept pace with the rising demand for cancer care. Hospitalization costs are increasing, and length of stay (LOS) remains a critical metric for hospital efficiency a...
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs [0.03%]
意大利肿瘤学家对补充疗法的处方倾向调查：症状和未满足患者需求
Maria Rosaria Valerio,Giuseppa Scandurra,Martina Greco et al.
Maria Rosaria Valerio et al.
Background/aim: A high percentage of cancer patients use complementary therapies (CM) during their disease journey. Several barriers for CM prescription still exist among oncologists. This study explored oncologists' atti...
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) [0.03%]
意大利肿瘤学会（AIOM）指南在真实世界中的生存分析：意大利胰腺导管腺癌辅助和一线治疗的多机构基于调查的队列研究（GARIBALDI）
M Reni,M Milella,F Bergamo et al.
M Reni et al.
Background: Non-metastatic pancreatic ductal adenocarcinoma (PDAC) presents a challenging scenario: the rarity of the disease, the limited number of completed prospective trials, and the shortcomings of comparability acro...
Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology [0.03%]
意大利肿瘤学协会关于转移性前列腺癌BRCA 1-2基因突变检测的调查结果
Isabella Saporita,Mariangela Calabrese,Stefano Poletto et al.
Isabella Saporita et al.
Background: 20% of prostate cancer (PC) patients harbor germinal or somatic alterations in homologous recombination repair (HRR) genes, including BRCA1/2. BRCA mutations represent predictive biomarkers for treatment with ...
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey [0.03%]
意大利肿瘤学协会(GARIBALDI调查)转移性队列的生存分析
M Reni,E Giommoni,F Bergamo et al.
M Reni et al.
This analysis from the GARIBALDI study was aimed to address the role of center self-declared expertise, type and commitment on the overall survival (OS) of patients with metastatic Pancreatic Ductal Adenocarcinoma (mPDAC). Treatment-naïve ...
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper [0.03%]
意大利肿瘤学家、糖尿病学家和内分泌学专家多学科共识意见书：癌症患者的糖尿病管理
N Silvestris,T Franchina,M Gallo et al.
N Silvestris et al.
Cancer management has significantly evolved in recent years, focusing on a multidisciplinary team approach to provide the best possible patient care and address the various comorbidities, toxicities, and complications that may arise during ...
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology [0.03%]
意大利肿瘤学家和传染病疫苗接种：意大利医学肿瘤协会调查结果
Angioletta Lasagna,Antonella Brunello,Nicola Silvestris et al.
Angioletta Lasagna et al.
Background: Patients with cancer present a higher risk of vaccine-preventable diseases. Recommended vaccinations are the most cost-effective measure to reduce the risk of transmission and related complications. Neverthele...
Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology [0.03%]
意大利肿瘤学会两项全国调查关于变性人和性别多样人群的癌症照护结果：供者与受试者的观点
A G Leone,R Miceli,D Trapani et al.
A G Leone et al.
Background: Transgender and gender-diverse (TGD) population represents an underserved group across the cancer care continuum. To assess the perspective of both oncology health care providers (OHPs) and TGD individuals in ...
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view [0.03%]
二型糖尿病与癌症发病过程中的共同途径：微小核糖核酸失调：意大利肿瘤学协会/意大利医学糖尿病学会/意大利糖尿病学会/意大利内分泌学会/意大利药理学会多学科观点
A Natalicchio,M Montagnani,M Gallo et al.
A Natalicchio et al.
Increasing evidence suggests that patients with diabetes, particularly type 2 diabetes (T2D), are characterized by an increased risk of developing different types of cancer, so cancer could be proposed as a new T2D-related complication. On ...
Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement [0.03%]
意大利医学肿瘤协会关于COVID-19对意大利肿瘤学影响及未来之路的立场文件：2021年玛特拉声明
G D Beretta,R Casolino,D C Corsi et al.
G D Beretta et al.
The coronavirus disease 2019 (COVID-19) pandemic has severely affected cancer care and research by disrupting the prevention and treatment paths as well as the preclinical, clinical, and translational research ecosystem. In Italy, this has ...
耗时 0.22486 秒，为您在
48229835
条记录里面共找到 61 篇文章 [XML]